Opna Bio

Developer of therapeutics for the treatment of cancer

placeEpalinges, Vaud, Switzerland calendar_todayFounded 2022 groups17 employees language opnabio.com

Innovation

13 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport; filing pace accelerating. Cited 317 times.

YearFilings
20201
20211
20221
20234
20249
202510
20263

Social engagement

Social engagement: 1.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Longitude Capital, Northpond Ventures.

Investor typeCountShare
Venture capital267%
Private equity133%

Recent activity

15 Apr 2026
Milestone
regulatory
21 Jan 2026
Milestone
regulatory
5 Nov 2025
Event
American Society for Hematology (ASH) Annual Meeting
Coming soon